Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Intravitreal Ranibizumab Injection for Diabetic Vitreous Hemorrhage: A Prospective Interventional Cohort Study

NCT07690800 is registered in ClinicalTrials.gov with Benha University as lead sponsor.

NCT NCT07690800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07690800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Intravitreal Ranibizumab Injection for Diabetic Vitreous Hemorrhage: A Prospective Interventional Cohort Study
Lead sponsor
Benha University
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2025
Completion date
April 1, 2026
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic vitreous hemorrhage, intravitreal injections, ranibizumab